GLP-1, Parkinson's Disease, and Neuroprotection

N Engl J Med. 2024 Apr 4;390(13):1233-1234. doi: 10.1056/NEJMe2401743.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Disease Models, Animal
  • Glucagon-Like Peptide 1* / agonists
  • Humans
  • Neuroprotection / drug effects
  • Neuroprotective Agents* / pharmacology
  • Neuroprotective Agents* / therapeutic use
  • Parkinson Disease* / drug therapy
  • Transcription Factors

Substances

  • Glucagon-Like Peptide 1
  • Neuroprotective Agents
  • Transcription Factors